Literature DB >> 7531842

Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity.

B K Smith1, D A York, G A Bray.   

Abstract

Acute central administration of galanin has been reported to increase fat consumption. These experiments were designed to test the hypothesis that repeated injections of galanin would elicit hyperphagia and weight gain and that this response would depend on the available diet. Male Sprague-Dawley rats were fed high (56% energy) or low (10% energy) fat diets. Galanin (300 pmol) or saline vehicle was injected into the third ventricle twice daily for 7 days and three times daily for another 6 days. On both the high-carbohydrate and high-fat diets, twice daily galanin increased daytime food intake, but there was a compensatory decrease in nighttime intake. The addition of a third, nighttime injection of galanin was ineffective in producing an increase in total 24-h intake. There was no significant increase in body weight during galanin treatment in rats eating either diet although animals eating the high-fat diet gained more weight as reflected by a significant increase in epididymal fat pad weight. Galanin treatment had no effects on serum insulin, glucose or corticosterone concentrations, measured at the end of the experiment. However, animals fed the high-fat diet had significantly higher insulin concentrations at the time of sacrifice. Although repeated central infusions of galanin reliably stimulated daytime intake of both diets, they failed to increase total daily energy intake or body weight.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531842     DOI: 10.1016/0196-9781(94)90152-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  13 in total

Review 1.  Drug treatment of obesity: from past failures to future successes?

Authors:  P Collins; G Williams
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

Review 2.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

3.  Regulation of feeding behavior, gastric emptying, and sympathetic nerve activity to interscapular brown adipose tissue by galanin and enterostatin: the involvement of vagal-central nervous system interactions.

Authors:  Hajime Nagase; Atsushi Nakajima; Hisahiko Sekihara; David A York; George A Bray
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 4.  Central nervous system regulation of food intake and energy expenditure: role of galanin-mediated feeding behavior.

Authors:  Peng-Hua Fang; Mei Yu; Yin-Ping Ma; Jian Li; Yu-Mei Sui; Ming-Yi Shi
Journal:  Neurosci Bull       Date:  2011-12       Impact factor: 5.203

Review 5.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

Review 6.  The MC4 receptor and control of appetite.

Authors:  R A H Adan; B Tiesjema; J J G Hillebrand; S E la Fleur; M J H Kas; M de Krom
Journal:  Br J Pharmacol       Date:  2006-10-16       Impact factor: 8.739

Review 7.  Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.

Authors:  M P McDonald; J N Crawley
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

8.  Obesity on a high-fat diet: role of hypothalamic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence.

Authors:  S F Leibowitz; A Akabayashi; J Wang
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

9.  Administration of Exendin-4 but not CCK alters lick responses and trial initiation to sucrose and intralipid during brief-access tests.

Authors:  Yada Treesukosol; Timothy H Moran
Journal:  Chem Senses       Date:  2022-01-01       Impact factor: 3.160

10.  Obesity and endocrine dysfunction in mice with deletions of both neuropeptide Y and galanin.

Authors:  J G Hohmann; D N Teklemichael; D Weinshenker; D Wynick; D K Clifton; R A Steiner
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.